National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

WT1-sensitized T cells
A population of allogeneic T-cells sensitized with Wilms tumor 1 (WT1) antigen with potential immunostimulatory and antineoplastic activities. Upon administration, WT1-sensitized T cells may bind to and lyse WT1-expressing tumor cells. WT1 antigen, a zinc finger DNA-binding protein acting as a transcriptional activator or repressor depending on the cellular or chromosomal context, is overexpressed in leukemic cells and in a vast number of nonhematological solid tumors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:white button mushroom extract, Winobanin, WinRho SDF, WT1 126-134 peptide vaccine, WT1-A10/AS01B immunotherapeutic GSK2130579A
Next:Wymox, xaliproden hydrochloride, Xanax, Xanthotoxin, Xcytrin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov